Related references
Note: Only part of the references are listed.CC Chemokine Receptor 5 Deficiency Does Not Prevent Local Immune Responses to Adenovirus Vector in Islet Transplant Recipients
Jun Cheng et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Hasan Korkaya et al.
CLINICAL CANCER RESEARCH (2011)
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals
J. H. Oh et al.
ONCOGENE (2011)
Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents
Xueping Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity
Masakatsu Fukuda et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Interleukin-2 induces NF-κB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells
Ka-Kui Chan et al.
JOURNAL OF PATHOLOGY (2010)
NF-κB and cancer: how intimate is this relationship
Sahdeo Prasad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
CCL5 increases lung cancer migration via PI3K Akt and NF-kappa B pathways
Chun-Yin Huang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis
Julio E. Valdivia-Silva et al.
CANCER LETTERS (2009)
Transient inhibition of NF-κB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation
Nazanin Dabaghmanesh et al.
CANCER SCIENCE (2009)
Chemokine Receptors as Targets for Cancer Therapy
Xuesong Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
CCL5/CCR5 Axis Promotes the Motility of Human Oral Cancer Cells
Jing-Yuan Chuang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Host-Derived Interleukin-1α Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells
Moshe Elkabets et al.
JOURNAL OF IMMUNOLOGY (2009)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
Marcus C. B. Tan et al.
JOURNAL OF IMMUNOLOGY (2009)
Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
Donatella Aldinucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Lung adenocarcinoma invasion in TGFbRII-deficient cells is mediated by CCL5/RANTES
A. C. Borczuk et al.
ONCOGENE (2008)
Sustained delivery of IL-1Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases
Galia Lavi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma
Hannes Seidl et al.
HUMAN PATHOLOGY (2007)
Interleukin-1β-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors
Yakov Krelin et al.
CANCER RESEARCH (2007)
Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion
Angela Sutton et al.
MOLECULAR CANCER RESEARCH (2007)
Inhibition of nuclear factor kappa B (NFκB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation
A Jewett et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice
Mi-La Cho et al.
JOURNAL OF IMMUNOLOGY (2006)
Interleukin-10 plasmid DNA inhibits subcutaneous tumor growth of Colon26 adenocarcinoma in mice
S Kokura et al.
CANCER LETTERS (2005)
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma
N Konishi et al.
ONCOLOGY (2005)
Interleukin-1 (IL-1α and IL-1β) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma
M Ricote et al.
CANCER (2004)
Nuclear factor-KB: a friend or a foe in cancer?
S Shishodia et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Nuclear factor-κB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression
S Shukla et al.
NEOPLASIA (2004)
Molecular profiling of inflammatory breast cancer:: Identification of a poor-prognosis gene expression signature
I Bièche et al.
CLINICAL CANCER RESEARCH (2004)
Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors
W Kazmierski et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Intracellular IL-1 Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-κB pathways
C Garat et al.
CYTOKINE (2003)
Host absence of CCR5 potentiates dendritic cell vaccination
J Ng-Cashin et al.
JOURNAL OF IMMUNOLOGY (2003)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel
TD Gilmore et al.
ONCOGENE (2001)
Role of intracellular interleukin-1 receptor antagonist in skin carcinogenesis
EH La et al.
MOLECULAR CARCINOGENESIS (2001)
Biological role of interleukin 1 receptor antagonist isoforms
WP Arend et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Share Paper
